Scailyte

Switzerland
Breíl, Grisons, Switzerland

Company profile

Scailyte company profile

Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discovery is radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-06-19

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
9
Total equity funding
$15.5M
Last funding
Series A / $1.8M / 2023-12-04
Last equity funding
Series A / $1.8M
Investors
8
Lead investors
3
Founders
4
Articles
39

Founders and investors

Founders

Daniel SonnleithnerDennis GohlsdorfManfred ClaassenPeter Nestorov

Lead investors

InnosuisseSwisscom VenturesVenture Kick

Investors

InnosuisseMassChallengeSwisscom VenturesVenture KickVerve Ventures